A 2022 review suggests that curcumin may reduce inflammation and speed up the process of wound healing by promoting the development of collagen and new blood vessels. However, a 2022 study notes ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ... by breaking down the fibrin, elastin, and collagen in wounds ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.